Binding of HMGA2 to these DNA conformations protected stalled replication forks from endonuclease digestion and conferred a survival advantage onto HMGA2+ cancer cells, including thyroid cancer cells, when exposed to chemotherapeutics such as hydroxyurea used in the treatment of cancer patients (45). The gene discussed is HMGA2; the disease is thyroid cancer.